Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model

다국어 초록 (Multilingual Abstract)

BACKGROUND: Mesenchymal stem cell (MSC)-based cell transplantation is an effective means of treating chronic liver injury, fibrosis and end-stage liver disease. However, extensive studies have found that only a small number of transplanted cells migrate to the site of injury or lesion, and repair efficacy is very limited.
METHODS: Bone marrow-derived MSCs (BM-MSCs) were generated that overexpressed the erythropoietin (EPO) gene using a lentivirus. Cell Counting Kit-8 was used to detect the viability of BM-MSCs after overexpressing EPO. Cell migration and apoptosis were verified using Boyden chamber and flow cytometry, respectively. Finally, the anti-fibrosis efficacy of EPO-MSCs was evaluated in vivo using immunohistochemical analysis.
RESULTS: EPO overexpression promoted cell viability and migration of BM-MSCs without inducing apoptosis, and EPO-MSC treatment significantly alleviated liver fibrosis in a carbon tetrachloride (CCl4) induced mouse liver fibrosis model.
CONCLUSION: EPO-MSCs enhance anti-fibrotic efficacy, with higher cell viability and stronger migration ability compared with treatment with BM-MSCs only. These findings support improving the efficiency of MSCs transplantation as a potential therapeutic strategy for liver fibrosis.

참고문헌 (Reference)

• 1 Sha M, "Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice" 79 : 106157-, 2020
• 2 Dolin CE, "The matrisome, inflammation, and liver disease" 40 : 180-188, 2020
• 3 Encabo-Berzosa MDM, "The effect of PEGylated hollow gold nanoparticles on stem cell migration : potential application in tissue regeneration" 9 : 9848-9858, 2017
• 4 Lin H, "The effect of EPO gene overexpression on proliferation and migration of mouse bone marrow-derived mesenchymal stem cells" 71 : 1365-1372, 2015
• 5 Hu C, "Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis" 23 : 1657-1670, 2019
• 6 Haghgoo SM, "Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease : a systematic review" 57 : 577-610, 2019
• 7 Wei B, "SP600125 enhances the antiapoptotic capacity and migration of bone marrow mesenchymal stem cells treated with tumor necrosis factor-alpha" 475 : 301-307, 2016
• 8 Tang Y, "Periostin promotes migration and osteogenic differentiation of human periodontal ligament mesenchymal stem cells via the Jun aminoterminal kinases(JNK)pathway under inflammatory conditions" 50 : e12369-, 2017
• 9 Wu S, "Paeonol alleviates CCl4-induced liver fibrosis through suppression of hepatic stellate cells activation via inhibiting the TGF-b/Smad3signaling" 41 : 438-445, 2019
• 10 Li J, "Mobilization of transplanted bone marrow mesenchymal stem cells by erythropoietin facilitates the reconstruction of segmental bone defect" 2019 : 5750967-, 2019
• 11 He L, "MiR-375inhibits the hepatocyte growth factor-elicited migration of mesenchymal stem cells by downregulating Akt signaling" 372 : 99-114, 2018
• 12 Hu C, "Mesenchymal stromal cells promote liver regeneration through regulation of immune cells" 16 : 893-903, 2020
• 13 Liu J, "Mesenchymal stem cell-conditioned media suppresses inflammation-associated overproliferation of pulmonary artery smooth muscle cells in a rat model of pulmonary hypertension" 11 : 467-475, 2016
• 14 Khatun M, "Mechanisms underlying hepatitis C virusassociated hepatic fibrosis" 8 : 1249-, 2019
• 15 Feng M, "Kupfferderived matrix metalloproteinase-9 contributes to liver fibrosis resolution" 14 : 1033-1040, 2018
• 16 Choi JS, "Human adipose derived stem cells exhibit enhanced liver regeneration in acute liver injury by controlled releasing hepatocyte growth factor" 52 : 935-950, 2019
• 17 Li J, "HIF1alpha attenuates neuronal apoptosis by upregulating EPO expression following cerebral ischemiareperfusion injury in a rat MCAO model" 45 : 1027-1036, 2020
• 18 Liu XY, "Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro" 14 : 3669-3675, 2016
• 19 Lu H, "Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment" 205 : 464-473, 2016
• 20 Chen LN, "Erythropoietin improves glucose metabolism and pancreatic b-cell damage in experimental diabetic rats" 12 : 5391-5398, 2015
• 21 Nakamura S, "Erythropoietin attenuates intestinal inflammation and promotes tissue regeneration" 50 : 1094-1102, 2015
• 22 Han XP, "EPO modified MSCs can inhibit asthmatic airway remodeling in an animal model" 119 : 1008-1016, 2018
• 23 Auzmendi J, "EPO And EPO-receptor system as potential actionable mechanism to protection of brain and heart in refractory epilepsy and SUDEP" 26 : 1356-1364, 2020
• 24 Attallah AM, "Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients" 12 : 44-53, 2013
• 25 Kamel MM, "Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models" 27 : 1329-1339, 2018
• 26 Zeng J, "Construction and identification of mouse BTLA lentiviral expression vector" 29 : 261-264, 2013
• 27 Karsdal MA, "Collagen biology and non-invasive biomarkers of liver fibrosis" 40 : 736-750, 2020
• 28 Elpek GO, "Cellular and molecular mechanisms in the pathogenesis of liver fibrosis : an update" 20 : 7260-7276, 2014
• 29 Zou GL, "Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-b/Smad signaling pathway" 25 : 4222-4234, 2019
• 30 Parekkadan B, "Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b ? splenocytes" 140 : 966-975, 2011
• 31 Naji A, "Biological functions of mesenchymal stem cells and clinical implications" 76 : 3323-3348, 2019
• 32 Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))method" 25 : 402-408, 2001
• 33 Sherman LS, "A discussion on adult mesenchymal stem cells for drug delivery : pros and cons" 6 : 1335-1346, 2015